Talking Blood Cancer: The strength within
Explore Vince O'Donnell's journey with hereditary amyloidosis. Hear about his resilience, treatments, and the role of genetic testing.
- Amyloidosis
Author: Michael Yare
From kidney stones to chemo
Wayne Douglas spent more than half a lifetime working with heavy rock and concrete in the civil construction industry. In 2018, Wayne joined the roughly 2,600 people diagnosed with myeloma in Australia each year.
- accommodation
- bone lesion
- chemotherapy
- exercise
- fatigue
- male
- Myeloma
- Peter MacCallum Cancer Centre
- regional
- rural
- Victoria
It can happen to anyone, anytime, anywhere and its unpreventable – the shocking truth behind Australia’s blood cancer crisis
The Leukaemia Foundation today revealed shocking new statistics proving just how prevalent blood cancer is in Australia, and that our country is in the middle of a blood cancer crisis.
Blood Cancer Taskforce unveils new Optimal Care Pathways for blood cancer treatment and care
Australia’s Blood Cancer Taskforce today released five new Optimal Care Pathways (OCPs), marking a significant advancement for blood cancer treatment and care in Australia.
Talking Blood Cancer: Finding Strength
Join Nerys Welch's journey through acute myeloid leukaemia (AML) / acute lymphoblastic leukaemia (ALL) loss and parenting 3 kids. Discover her solace in the Leukaemia Foundation's supportive online community.
- Acute lymphoblastic leukaemia
- Acute myeloid leukaemia
Treatment and transplant news
Once a blood cancer treatment is developed, it needs to be approved for sale in Australia and subsidised, or ‘listed’, otherwise the cost for the treatment can be unaffordable for many patients. The Medical Services Advisory Committee (MSAC) or Pharmaceutical Benefits Advisory Committee (PBAC) appraises a new treatment and provides advice to the Government on whether it should be publicly funded. This includes seeking consumer comments. Here’s a summary of recent new and recommended listings for blood cancer treatments. The Leukaemia Foundation provided advice and consumer comments to PBAC/MSAC in support of these therapies being available to patients.
- Advocacy and policy
- Treatments and side-effects
Blood cancer ride proves Perry’s toughest race
As Perry Judd slowly pedalled over the finishing line at the prestigious Grafton to Inverell Cycle Classic in 2013, supposedly in the form of his life but somehow lagging far behind the competition, he knew something wasn’t right. Physically exhausted, Perry feared he had glandular fever, but a blood test revealed something much more dangerous. The then 37-year-old explained: “I had a call from the GP: ‘Please come and see me, we need to talk urgently. You need to come in right away’.
- Acute myeloid leukaemia
- Treatments and side-effects
Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador
The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland and current CEO of the Australian Banking Association, Ms Bligh is a survivor of the blood cancer Non-Hodgkin lymphoma, after being diagnosed in 2013. Ms Bligh will immediately step into her role as National Ambassador, bringing with her a wealth of experience to passionately advocate for fellow Australians impacted by blood cancer.
- Media releases
- Non-Hodgkin lymphoma
Talking Blood Cancer: Mother-Daughter Cancer Warriors
Join Kate Arkadieff and Theresa Webb as they delve into non-Hodgkin's lymphoma & acute lymphoblastic leukaemia (leukemia) journeys for patients and families on the Talking Blood Cancer podcast by Leukaemia Foundation.
- Acute lymphoblastic leukaemia
- Non-Hodgkin lymphoma
The biggest challenge of cancer patients that nobody talks about…
It’s the number one challenge of people with cancer in Australia , yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment , and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher.
